<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Braz. J. Microbiol</journal-id><journal-id journal-id-type="publisher-id">bjm</journal-id><journal-title-group><journal-title>Brazilian Journal of Microbiology</journal-title></journal-title-group><issn pub-type="ppub">1517-8382</issn><issn pub-type="epub">1678-4405</issn><publisher><publisher-name>Sociedade Brasileira de Microbiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26273262</article-id><article-id pub-id-type="pmc">4507539</article-id><article-id pub-id-type="doi">10.1590/S1517-838246220120023</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medical Microbiology</subject></subj-group></article-categories><title-group><article-title>Nosocomial candidiasis in Rio de Janeiro State: Distribution and
fluconazole susceptibility profile</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Neufeld</surname><given-names>Paulo Murillo</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff05">5</xref><xref rid="c01" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Melhem</surname><given-names>Marcia de Souza Carvalho</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Szeszs</surname><given-names>Maria Walderez</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Ribeiro</surname><given-names>Marcos Dornelas</given-names></name><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>Amorim</surname><given-names>Efig&#x000ea;nia de Lourdes Teixeira</given-names></name><xref ref-type="aff" rid="aff04">4</xref></contrib><contrib contrib-type="author"><name><surname>da Silva</surname><given-names>Manuela</given-names></name><xref ref-type="aff" rid="aff05">5</xref></contrib><contrib contrib-type="author"><name><surname>Laz&#x000e9;ra</surname><given-names>Marcia dos Santos</given-names></name><xref ref-type="aff" rid="aff06">6</xref></contrib></contrib-group><aff id="aff01"><label>1</label>Universidade Federal do Rio de
Janeiro, Departamento de An&#x000e1;lises Cl&#x000ed;nicas e
Toxicol&#x000f3;gicas, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, RJ, Brasil, Departamento de An&#x000e1;lises Cl&#x000ed;nicas e
Toxicol&#x000f3;gicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ,
Brazil.</aff><aff id="aff02"><label>2</label>Instituto Adolfo Lutz, Servi&#x000e7;o de Parasitologia, Instituto Adolfo Lutz, S&#x000e3;o Paulo, SP, Brasil, Servi&#x000e7;o de Parasitologia, Instituto Adolfo
Lutz, S&#x000e3;o Paulo, SP, Brazil.</aff><aff id="aff03"><label>3</label>Servi&#x000e7;o de Patologia Cl&#x000ed;nica, Instituto Estadual de Hematologia Arthur da
Siqueira Cavalcante, Rio de Janeiro, RJ, Brasil, Servi&#x000e7;o de Patologia Cl&#x000ed;nica, Instituto
Estadual de Hematologia Arthur da Siqueira Cavalcante, Rio de Janeiro, RJ,
Brazil.</aff><aff id="aff04"><label>4</label>Setor de Microbiologia e Urin&#x000e1;lise, Laborat&#x000f3;rio S&#x000e9;rgio Franco, Rio de Janeiro, RJ, Brasil, Setor de Microbiologia e Urin&#x000e1;lise, Laborat&#x000f3;rio
S&#x000e9;rgio Franco, Rio de Janeiro, RJ, Brazil.</aff><aff id="aff05"><label>5</label>Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Instituto Nacional de Controle de Qualidade em
Sa&#x000fa;de, Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Rio de Janeiro, RJ, Brasil, Instituto Nacional de Controle de Qualidade em
Sa&#x000fa;de, Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</aff><aff id="aff06"><label>6</label>Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Laborat&#x000f3;rio de Micologia, Instituto de Pesquisa Cl&#x000ed;nica Hospital Evandro
Chagas, Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Rio de Janeiro, RJ, Brasil, Laborat&#x000f3;rio de Micologia, Instituto de Pesquisa
Cl&#x000ed;nica Hospital Evandro Chagas, Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Rio de Janeiro, RJ,
Brazil.</aff><author-notes><corresp id="c01">Send correspondence to P.M. Neufeld. Departamento de An&#x000e1;lises
Cl&#x000ed;nicas e Toxicol&#x000f3;gicas, Faculdade de Farm&#x000e1;cia, Universidade Federal do Rio de
Janeiro, Pr&#x000e9;dio do CCS, bloco A2, sala 029, Cidade Universit&#x000e1;ria, 21941-590 Rio
de Janeiro, RJ, Brazil. E-mail:
<email>pmneufeld@pharma.ufrj.br</email>.</corresp><fn id="fn01" fn-type="other"><p>Associate Editor: Carlos Pelleschi Taborda</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2015</year></pub-date><volume>46</volume><issue>2</issue><fpage>477</fpage><lpage>484</lpage><history><date date-type="received"><day>14</day><month>8</month><year>2012</year></date><date date-type="accepted"><day>08</day><month>12</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015, Sociedade Brasileira de
Microbiologia</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>All the content of the journal, except where otherwise noted, is
licensed under a Creative Commons License CC BY-NC.</license-p></license></permissions><abstract><p>One hundred and forty-one <italic>Candida</italic> species isolated from clinical
specimens of hospitalized patients in Rio de Janeiro, Brazil, during 2002 to
2007, were analized in order to evaluate the distribution and susceptibility of
these species to fluconazole. <italic>Candida albicans</italic> was the most
frequent species (45.4%), followed by <italic>C. parapsilosis sensu
lato</italic> (28.4%), <italic>C. tropicalis</italic> (14.2%), <italic>C.
guilliermondii</italic> (6.4%), <italic>C. famata</italic> (2.8%),
<italic>C. glabrata</italic> (1.4%), <italic>C. krusei</italic> (0.7%) and
<italic>C. lambica</italic> (0.7%). The sources of fungal isolates were
blood (47.5%), respiratory tract (17.7%), urinary tract (16.3%), skin and mucous
membrane (7.1%), catheter (5.6%), feces (2.1%) and mitral valve tissue (0.7%).
The susceptibility test was performed using the methodology of disk-diffusion in
agar as recommended in the M44-A2 Document of the Clinical and Laboratory
Standards Institute (CLSI). The majority of the clinical isolates (97.2%) was
susceptible (S) to fluconazole, although three isolates (2.1%) were
susceptible-dose dependent (S-DD) and one of them (0.7%) was resistant (R). The
S-DD isolates were <italic>C. albicans</italic>, <italic>C. parapsilosis sensu
lato</italic> and <italic>C. tropicalis</italic>. One isolate of <italic>C.
krusei</italic> was resistant to fluconazole. This work documents the high
susceptibility to fluconazole by <italic>Candida</italic> species isolated in
Rio de Janeiro, Brazil.</p></abstract><kwd-group><kwd><italic>Candida</italic></kwd><kwd>fluconazole</kwd><kwd>antifungal susceptibility</kwd><kwd>disk diffusion method</kwd></kwd-group><counts><fig-count count="0"/><table-count count="4"/><equation-count count="0"/><ref-count count="52"/><page-count count="8"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Since the 1980 decade, invasive fungal infections have grown considerably and the
focus of this process has been immunocompromised patients (<xref rid="B08" ref-type="bibr">Beck-Sagu&#x000e9; and Jarvis, 1993</xref>; <xref rid="B22" ref-type="bibr">Martin <italic>et al.</italic>, 2003</xref>). Among the factors
that make the defense system fragile and the individuals susceptible to a variety of
opportunistic fungi are the seriousness of the base disease, time of permanence in
the intensive therapy unit, antibiotic therapy of large spectrum, chemotherapy,
radiotherapy, immunosuppressive therapy, central venous catheter, total parenteral
feeding, attended ventilation, burns, abdominal surgeries and organ as well as bone
marrow transplantations (<xref rid="B14" ref-type="bibr">Colombo and Guimar&#x000e3;es,
2003</xref>; <xref rid="B15" ref-type="bibr">Colombo <italic>et al.</italic>,
2007</xref>; <xref rid="B32" ref-type="bibr">Pem&#x000e1;n and Salavert, 2012</xref>).
Although, new fungal species are described each year as agents of nosocomial
infection (<xref rid="B10" ref-type="bibr">Chakrabarti and Singh, 2011</xref>; <xref rid="B28" ref-type="bibr">Nucci and Marr, 2005</xref>), <italic>Candida</italic>
spp. are still considered as the most current pathogen (<xref rid="B02" ref-type="bibr">Alangaden, 2011</xref>; <xref rid="B34" ref-type="bibr">Pfaller
<italic>et al.</italic>, 2006a</xref>). Based on the literature, <italic>C.
albicans</italic> is detected in the majority of the cases in Latin America
followed by <italic>C. tropicalis</italic>, <italic>C. parapsilosis sensu
lato</italic>, and <italic>C. glabrata</italic> (<xref rid="B37" ref-type="bibr">Pfaller <italic>et al.</italic>, 2010</xref>). Nevertheless, <italic>C.
famata</italic>, <italic>C. kefyr</italic>, <italic>C. guilliermondii</italic>,
<italic>C. lusitaniae</italic>, <italic>C. pelliculosa</italic> and <italic>C.
rugosa</italic> have presented increasing isolation rates (<xref rid="B13" ref-type="bibr">Colombo <italic>et al.</italic>, 2006</xref>; <xref rid="B23" ref-type="bibr">Matta <italic>et al.</italic>, 2007</xref>; <xref rid="B36" ref-type="bibr">Pfaller and Diekema, 2007</xref>).</p><p>Due to the long use for fluconazole to the invasive candidiasis treatment, strains of
non-<italic>albicans</italic> species with low susceptibility have appeared in
the hospital ambient (<xref rid="B11" ref-type="bibr">Chen <italic>et al.</italic>,
2012</xref>). As the resistance to fluconazole can be the cause of therapeutic
failure, the fast identification of the etiologic agent and the analysis of the
susceptibility profile to the antifungal drugs can help to decide the most
appropriate treatment (<xref rid="B26" ref-type="bibr">Montravers and Jabbour,
2006</xref>; <xref rid="B36" ref-type="bibr">Pfaller and Diekema, 2007</xref>;
<xref rid="B45" ref-type="bibr">Shah <italic>et al.</italic>, 2011</xref>).</p><p>The method employed to evaluate antifungal susceptibility must present a good
clinical correlation and has to be reproducible (<xref rid="B18" ref-type="bibr">Hospenthal <italic>et al.</italic>, 2004</xref>; <xref rid="B20" ref-type="bibr">Lass-Fl&#x000f6;rl <italic>et al.</italic>, 2010</xref>). Within this
context, an effort has been made by the Clinical and Laboratory Standards Institute
- CLSI, which developed a reference test to evaluate the <italic>in vitro</italic>
susceptibility of <italic>Candida</italic> spp. to fluconazole (<xref rid="B12" ref-type="bibr">CLSI, 2009</xref>), using the disk-diffusion in agar methodology
(M44-A2). Due to its simplicity, facility of execution and low cost, this method can
be easily incorporated in the routine of the public and private clinical
laboratories, working as a predictor of clinical response as well as a tool of
surveillance and control of the emergence of <italic>Candida</italic> spp. strains
with low sensitivity to fluconazole (<xref rid="B41" ref-type="bibr">Pfaller
<italic>et al.</italic>, 2004</xref>).</p><p>The present study describes the distribution of <italic>Candida</italic> species
isolated from clinical specimens obtained from hospitalized adult and infant
patients in Rio de Janeiro, Brazil, and their susceptibility profile to fluconazole
employing the agar disk diffusion method described by CLSI (<xref rid="B12" ref-type="bibr">CLSI, 2009</xref>).</p></sec><sec sec-type="materials|methods"><title>Material and Methods</title><sec><title>Samples</title><p>One hundred and forty-one nosocomial isolates of <italic>Candida</italic> spp.
(one isolate by patient) were obtained from 2002 to 2007 from five medical
centers (a tertiary teaching hospital, a tertiary private hospital, a tertiary
militar hospital, a hematological and hemotherapic center and an university
pediatric center), one public and one private laboratory of clinical analyses,
all of them located in the City of Rio de Janeiro. Despite this localization,
the nosocomial samples came from different regions of the State of Rio de
Janeiro. In this investigation, the hospital-acquired infections were those that
were diagnosed while the patient was hospitalized in the assistance unit.
<italic>Candida</italic> species were isolated from blood, catheter,
gastrointestinal tract, genitourinary tract, skin lesions and mitral valve
tissue from adult and infant immunocompromised patients. The identification of
<italic>Candida</italic> isolates and the fluconazole disk diffusion
susceptibility testing were performed at the Clinical Mycology Laboratory of
Pharmacy College of the Federal University of Rio de Janeiro and at the Mycology
Sector of Parasitology Service of Adolfo Lutz Institute, S&#x000e3;o Paulo, Brazil. All
information about the samples were obtained from the data records sent with
requests for mycological analyses. However, many of them were incomplete. Thus,
it was not possible to classify all samples studied.</p></sec><sec><title>Yeast Identification</title><p>All isolates of <italic>Candida</italic> species were identified based on their
morphophysiological characteristics. The cultivation in
CHROMagar-<italic>Candida</italic> medium (Company, France) was performed to
confirm the viability and pureness, as well as for a preliminary identification
of the isolates by the production of chromogen pigments (green: <italic>C.
albicans</italic>, blue: <italic>C. tropicalis</italic> and rose: <italic>C.
krusei</italic>) (<xref rid="B29" ref-type="bibr">Odds and Bernaerts,
1994</xref>). The observation of the formation of germinative tube in human
serum and the production of chlamydospores in cornmeal agar (Oxoid, England)
with tween 80 (Reagen, Brazil) was performed in order to identify <italic>C.
albicans</italic> (<xref rid="B17" ref-type="bibr">Dalmau, 1929</xref>;
<xref rid="B46" ref-type="bibr">Taschdjian <italic>et al.</italic>,
1960</xref>). The biochemical identification was conducted through the Vitek
commercial system (BioMerieux, France) according to the manufacturer
recommendation. The isolates were maintained in sterile distilled water at room
temperature up to the moment of the susceptibility tests.</p><sec><title>Antifungal Susceptibility Testing</title><p>The agar disk-diffusion test was performed in accordance to the methodology
described in M44-A2 document published by CLSI (<xref rid="B12" ref-type="bibr">CLSI, 2009</xref>). Paper disks containing 25 &#x003bc;g of
fluconazole (CECON, Brazil) and Petri dishes (90 mm of diameter) containing
Mueller-Hinton agar (Difco, England) supplemented with 2% of glycose and 0.5
&#x003bc;g mL<sup>&#x02212;1</sup> of methylene blue at a depth of 4.0 mm were used. In
order to monitor the precision, accuracy and performance of the test,
<italic>Candida albicans</italic> ATCC 90028 and <italic>Candida
parapsilosis</italic> ATCC 22019 were used as control strains. Each
isolate of <italic>Candida</italic> spp. was subcultivated into plates with
Sabouraud dextrose agar (Difco, England), which were incubated at 35&#x02013;37 &#x000b0;C
for 24 h. Five colonies of the isolates were collected and suspended in 5 mL
of sterile saline (0.85%).</p><p>The turbidity suspension was adjusted to the 0.5 McFarland scale
(10<sup>6</sup> cell/mL) in a spectrophotometer (Biospectro, Brazil)
using 530 nm wavelength. The yeast suspension was inoculated using a sterile
swab over the surface of agar Mueller-Hinton. The disk with fluconazole was
aseptically deposited over the inoculated agar and the plate was incubated
aerobically at a 35&#x02013;37 &#x000b0;C temperature for 24 h. The diameter of the
inhibition area was measured for determining the susceptibility and
calculating the minimal inhibitory concentration (MIC). The interpretative
criteria of the fluconazole disk-diffusion test were those suggested by CLSI
7: susceptible (S): &#x02265; 19 mm; susceptible-dose dependent (S-DD): 15&#x02013;18 mm;
resistant (R): &#x02264; 14 mm. The values of the corresponding MIC to these
diameters CLSI (<xref rid="B12" ref-type="bibr">CLSI, 2009</xref>) are the
following: S: MIC &#x02264; 8 &#x003bc;g mL<sup>&#x02212;1</sup>; S-DD: MIC 16&#x02013;32 &#x003bc;g
mL<sup>&#x02212;1</sup>; R: MIC &#x02265; 64 &#x003bc;g mL<sup>s;1</sup>. The quality control test
was conducted every day during the procedure according to CLSI (<xref rid="B12" ref-type="bibr">CLSI, 2009</xref>) and the results obtained
were within expected limit for each control strain.</p></sec></sec></sec><sec sec-type="results"><title>Results</title><p>The distribution of <italic>Candida</italic> species at the seven health institutions
involved in this investigation is presented in <xref rid="t01" ref-type="table">Table 1</xref>. From the total of isolations, 43.3% occurred in the Hemotherapy
and Hematology Center. The largest percentage of recovery of
<italic>Candida</italic> spp. from blood stream infections (46.3%) was also
observed in this same institution. In the present study, <italic>Candida
albicans</italic> (<xref rid="t01" ref-type="table">Table 1</xref>) was the
yeast with the largest isolation rate (45.4%), followed by <italic>C. parapsilosis
sensu lato</italic> (28.4%), <italic>C. tropicalis</italic> (14.2%), <italic>C.
guilliermondii</italic> (6.4%) and <italic>C. famata</italic> (2.8%), besides
<italic>C. glabrata</italic> (1.4%), <italic>C. krusei</italic> (0.7%) and
<italic>C. lambica</italic> (0.7%). The isolates of <italic>Candida</italic>
here evaluated were obtained from hospitalized patients with different risk factors,
among them, onco-hematological diseases, solid tumors and AIDS.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><title>Distribution of <italic>Candida</italic> clinical isolates by health
centers.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Center</th><th colspan="8" valign="top" align="center" rowspan="1">Number of isolates (%)</th><th valign="top" align="center" rowspan="1" colspan="1">Total [No. (%)]</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th colspan="8" valign="top" align="left" rowspan="1">
<hr/>
</th><th valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. albicans</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. parapsilosis [sensu lato]</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. tropicalis</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. guilliermondii</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. famata</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. glabrata</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. krusei</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. lambica</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Tertiary teaching hospital</td><td valign="top" align="center" rowspan="1" colspan="1">03 (60)</td><td valign="top" align="center" rowspan="1" colspan="1">01 (20)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (20)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">05 (3.5)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Terctiary private hospital</td><td valign="top" align="center" rowspan="1" colspan="1">09 (81.8)</td><td valign="top" align="center" rowspan="1" colspan="1">01 (9.1)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (9.1)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (7.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tertiary militar hospital</td><td valign="top" align="center" rowspan="1" colspan="1">02 (100)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">02 (1.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hematological and hemotherapic center</td><td valign="top" align="center" rowspan="1" colspan="1">18 (29.5)</td><td valign="top" align="center" rowspan="1" colspan="1">27 (44.3)</td><td valign="top" align="center" rowspan="1" colspan="1">05 (8.2)</td><td valign="top" align="center" rowspan="1" colspan="1">07 (11.5)</td><td valign="top" align="center" rowspan="1" colspan="1">04 (6.5)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">61 (43.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pediatric university center</td><td valign="top" align="center" rowspan="1" colspan="1">07 (41.2)</td><td valign="top" align="center" rowspan="1" colspan="1">06 (35.3)</td><td valign="top" align="center" rowspan="1" colspan="1">03 (17.6)</td><td valign="top" align="center" rowspan="1" colspan="1">01 (5.9)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">17 (12.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Public clinical laboratory</td><td valign="top" align="center" rowspan="1" colspan="1">09 (56.2)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (12.5)</td><td valign="top" align="center" rowspan="1" colspan="1">03 (18.7)</td><td valign="top" align="center" rowspan="1" colspan="1">01 (6.3)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (6.3)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">16 (11.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Private clinical laboratory</td><td valign="top" align="center" rowspan="1" colspan="1">16 (55.2)</td><td valign="top" align="center" rowspan="1" colspan="1">03 (10.3)</td><td valign="top" align="center" rowspan="1" colspan="1">09 (31)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.5)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">29 (20.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Overall</td><td valign="top" align="center" rowspan="1" colspan="1">64 (45.4)</td><td valign="top" align="center" rowspan="1" colspan="1">40 (28.4)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (14.2)</td><td valign="top" align="center" rowspan="1" colspan="1">09 (6.4)</td><td valign="top" align="center" rowspan="1" colspan="1">04 (2.8)</td><td valign="top" align="center" rowspan="1" colspan="1">02 (1.4)</td><td valign="top" align="center" rowspan="1" colspan="1">01 (0.7)</td><td valign="top" align="center" rowspan="1" colspan="1">01 (0.7)</td><td valign="top" align="center" rowspan="1" colspan="1">141 (100)</td></tr></tbody></table></table-wrap><p>Blood (47.5%), respiratory tract (17.7%), urinary tract (16.3%), skin and mucous
membrane (7.1%), catheter (5.6%), feces (2.1%) and biopsy of the mitral valve (0.7%)
were the sources of isolation. It was not possible to define anatomical localization
for 3.0% of the isolates. The distribution of <italic>Candida</italic> isolates by
clinical specimens is summarized in the <xref rid="t02" ref-type="table">Table
2</xref>. <italic>C. albicans</italic> and <italic>C. parapsilosis sensu
lato</italic> were the most frequent species isolates from hemoculture,
presenting rates of 41.8% and 37.3%, respectively. Other yeasts isolated from
hemoculture were <italic>C. tropicalis</italic> (10.4%), <italic>C.
guilliermondii</italic> (6.0%), <italic>C. famata</italic> (3.0%) and <italic>C.
glabrata</italic> (1.5%). From samples of catheter only <italic>C.
albicans</italic> (62.5%) and <italic>C. parapsilosis sensu lato</italic>
(37.5%) were isolated. The single isolate of <italic>C. krusei</italic> was
retrieved from respiratory specimens.</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><title>Distribution of <italic>Candida</italic> isolates by clinical
specimens.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Species</th><th colspan="8" valign="top" align="center" rowspan="1">Number of isolates (%)</th><th valign="top" align="center" rowspan="1" colspan="1">Total [No. (%)]</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th colspan="8" valign="top" align="left" rowspan="1">
<hr/>
</th><th valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">Blood</th><th valign="top" align="center" rowspan="1" colspan="1">Catheter</th><th valign="top" align="center" rowspan="1" colspan="1">Urinay tract</th><th valign="top" align="center" rowspan="1" colspan="1">Respiratory tract</th><th valign="top" align="center" rowspan="1" colspan="1">Skin/soft tissue</th><th valign="top" align="center" rowspan="1" colspan="1">Stool</th><th valign="top" align="center" rowspan="1" colspan="1">Mitral valve</th><th valign="top" align="center" rowspan="1" colspan="1">NC</th><th valign="top" align="center" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. albicans</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">28 (41.8)</td><td valign="top" align="center" rowspan="1" colspan="1">05 (62.5)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (56.6)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (48)</td><td valign="top" align="center" rowspan="1" colspan="1">03 (30)</td><td valign="top" align="center" rowspan="1" colspan="1">02 (66.7)</td><td valign="top" align="center" rowspan="1" colspan="1">01 (100)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">64 (45.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. parapsilosis [sensu lato]</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">25 (37.3)</td><td valign="top" align="center" rowspan="1" colspan="1">03 (37.5)</td><td valign="top" align="center" rowspan="1" colspan="1">04 (17.4)</td><td valign="top" align="center" rowspan="1" colspan="1">03 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">05 (50)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">40 (28.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. tropicalis</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">07 (10.4)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">02 (8.7)</td><td valign="top" align="center" rowspan="1" colspan="1">07 (28)</td><td valign="top" align="center" rowspan="1" colspan="1">01 (10)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">03 (75)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (14.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. guilliermondii</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">04 (6)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">03 (13)</td><td valign="top" align="center" rowspan="1" colspan="1">01 (4)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (33.3)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">09 (6.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. famata</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">02 (3)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (4.3)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (25)</td><td valign="top" align="center" rowspan="1" colspan="1">04 (2.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. glabrata</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">01 (1.5)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (10)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">02 (1.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. krusei</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (4)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (0.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. lambica</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (4)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">01 (0.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">67 (47.5)</td><td valign="top" align="center" rowspan="1" colspan="1">08 (5.6)</td><td valign="top" align="center" rowspan="1" colspan="1">23 (16.3)</td><td valign="top" align="center" rowspan="1" colspan="1">25 (17.7)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (7.1)</td><td valign="top" align="center" rowspan="1" colspan="1">03 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1">01 (0.7)</td><td valign="top" align="center" rowspan="1" colspan="1">04 (3)</td><td valign="top" align="center" rowspan="1" colspan="1">141 (100)</td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><p>NC, not-classified specimens.</p></fn></table-wrap-foot></table-wrap><p>The diameters of inhibition zones produced by the agar disk-diffusion for all of the
isolates tested varied from 10 to 50 mm with average value of 35.8 mm. <xref rid="t03" ref-type="table">Table 3</xref> presents the intervals and the means
of the diameters from the inhibition zone for <italic>Candida</italic> species
regarding the relationship to different anatomical sites. Among the species,
<italic>C. krusei</italic> (10 mm) presented the smallest inhibition diameter.
<italic>C. albicans</italic> (38.6 mm), <italic>C. parapsilosis sensu
lato</italic> (36.5 mm) and <italic>C. guilliermondii</italic> (33 mm) were the
species that produced diameters with higher average values. Based on diameters size
of the inhibition zone, the general profile of susceptibility to fluconazole was the
following: 0.7% of the isolates were resistant (MIC &#x02265; 64 &#x003bc;g mL<sup>&#x02212;1</sup>), 2.1%
were susceptible-dose dependent (MIC 16&#x02013;32 &#x003bc;g mL<sup>&#x02212;1</sup>) and 97.2% were
susceptible (MIC &#x02264; 8&#x003bc;g mL<sup>&#x02212;1</sup>). <xref rid="t04" ref-type="table">Table
4</xref> shows the susceptibility to fluconazole separately by species. The
resistance to fluconazole was a phenomenon restricted to the only isolate of
<italic>C. krusei</italic> in the present investigation. <italic>C.
albicans</italic>, <italic>C. parapsilosis sensu lato</italic> and <italic>C.
tropicalis</italic>, although clearly susceptible, also were susceptible-dose
dependent isolates. The other species, <italic>C. famata</italic>, <italic>C.
glabrata</italic>, <italic>C. guilliermondii</italic> and <italic>C.
lambica</italic> presented susceptibility rates of 100%.</p><table-wrap id="t03" orientation="portrait" position="float"><label>Table 3</label><caption><title>Range and average zone diameters (mm) by <italic>Candida</italic>
isolates and specimen types.</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" valign="top" align="left" colspan="1">Specimens</th><th colspan="8" valign="top" align="center" rowspan="1">Range (average) [mm]</th><th rowspan="3" valign="top" align="center" colspan="1">Total range (average)</th></tr><tr><th colspan="8" valign="top" align="left" rowspan="1">
<hr/>
</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. albicans</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. parapsilosis</italic>
[<italic>sensu lato</italic>]</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. tropicalis</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. guilliermondii</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. famata</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. glabrata</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. krusei</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<italic>C. lambica</italic>
</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Blood</td><td valign="top" align="center" rowspan="1" colspan="1">16&#x02013;40 (40.2)</td><td valign="top" align="center" rowspan="1" colspan="1">15&#x02013;50 (37.2)</td><td valign="top" align="center" rowspan="1" colspan="1">26&#x02013;37 (30.5)</td><td valign="top" align="center" rowspan="1" colspan="1">28&#x02013;36 (32.5)</td><td valign="top" align="center" rowspan="1" colspan="1">30&#x02013;32 (31)</td><td valign="top" align="center" rowspan="1" colspan="1">35</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">15&#x02013;50 (37.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Catheter</td><td valign="top" align="center" rowspan="1" colspan="1">30&#x02013;48 (40.8)</td><td valign="top" align="center" rowspan="1" colspan="1">22&#x02013;44 (36.6)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">22&#x02013;48 (39.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Urinary tract</td><td valign="top" align="center" rowspan="1" colspan="1">30&#x02013;44 (39.9)</td><td valign="top" align="center" rowspan="1" colspan="1">30&#x02013;38 (34.7)</td><td valign="top" align="center" rowspan="1" colspan="1">30&#x02013;33 (31.5)</td><td valign="top" align="center" rowspan="1" colspan="1">26&#x02013;38 (32)</td><td valign="top" align="center" rowspan="1" colspan="1">34</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">26&#x02013;44 (34.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Repiratory tract</td><td valign="top" align="center" rowspan="1" colspan="1">30&#x02013;47 (37)</td><td valign="top" align="center" rowspan="1" colspan="1">30&#x02013;36 (33.2)</td><td valign="top" align="center" rowspan="1" colspan="1">30&#x02013;36 (33.6)</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">10&#x02013;47 (33)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Skin/soft tissue</td><td valign="top" align="center" rowspan="1" colspan="1">32&#x02013;50 (38.3)</td><td valign="top" align="center" rowspan="1" colspan="1">30&#x02013;48 (37.2)</td><td valign="top" align="center" rowspan="1" colspan="1">38</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">20&#x02013;50 (35.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stool</td><td valign="top" align="center" rowspan="1" colspan="1">32&#x02013;46 (39)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">33</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">32&#x02013;46 (37)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mitral valve</td><td valign="top" align="center" rowspan="1" colspan="1">37</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">37</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">NC</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">15&#x02013;35 (26)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">25</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">15&#x02013;35 (25.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">16&#x02013;50 (38.6)</td><td valign="top" align="center" rowspan="1" colspan="1">15&#x02013;50 (36.5)</td><td valign="top" align="center" rowspan="1" colspan="1">15&#x02013;38 (31.2)</td><td valign="top" align="center" rowspan="1" colspan="1">20&#x02013;38 (33)</td><td valign="top" align="center" rowspan="1" colspan="1">25&#x02013;34 (30.2)</td><td valign="top" align="center" rowspan="1" colspan="1">20&#x02013;35 (27.5)</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">10&#x02013;50 (35.8)</td></tr></tbody></table><table-wrap-foot><fn id="TFN02"><p>NC, not-classified specimens.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t04" orientation="portrait" position="float"><label>Table 4</label><caption><title>Fluconazole susceptibility of 141 <italic>Candida</italic> clinical
isolates.</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" valign="top" align="left" colspan="1">Species</th><th rowspan="3" valign="top" align="center" colspan="1">Clinical specimens</th><th colspan="3" valign="top" align="center" rowspan="1">Fluconazole susceptibility
category (%)</th></tr><tr><th colspan="3" valign="top" align="left" rowspan="1">
<hr/>
</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">S</th><th valign="top" align="center" rowspan="1" colspan="1">S-DD</th><th valign="top" align="center" rowspan="1" colspan="1">R</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. albicans</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Blood</td><td valign="top" align="center" rowspan="1" colspan="1">96.4</td><td valign="top" align="center" rowspan="1" colspan="1">3.6</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Non-blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">All</td><td valign="top" align="center" rowspan="1" colspan="1">98.4</td><td valign="top" align="center" rowspan="1" colspan="1">1.6</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. parapsilosis [sensu lato]</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Blood</td><td valign="top" align="center" rowspan="1" colspan="1">96</td><td valign="top" align="center" rowspan="1" colspan="1">4.0</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Non-blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">All</td><td valign="top" align="center" rowspan="1" colspan="1">97.5</td><td valign="top" align="center" rowspan="1" colspan="1">2.5</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. tropicalis</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Non-blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">NC</td><td valign="top" align="center" rowspan="1" colspan="1">66.7</td><td valign="top" align="center" rowspan="1" colspan="1">33.3</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">All</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. guilliermondii</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Non-blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">All</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. famata</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Non-blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">NC</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">All</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. glabrata</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Non-blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">All</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. krusei</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Blood</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Non-blood</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">100</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">All</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">100</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>C. lambica</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Blood</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Non-blood</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">All</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Overall</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">97.2</td><td valign="top" align="center" rowspan="1" colspan="1">2.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.7</td></tr></tbody></table><table-wrap-foot><fn id="TFN03"><p>S, susceptible; S-DD, susceptible-dose dependent; R, resistant; NC,
not-classified specimens.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>From the medical centers analyzed, the one specialized in the treatment of
hematological patients was the center that presented the largest rate of fungal
isolation, including isolates from hemocultures (46.3%). Because of its consumptive
nature and its more aggressive treatment protocols, the hematological pathologies,
in general, make the patients extremely susceptible to invasive fungal infections,
therefore becoming one of the major risk factors (<xref rid="B52" ref-type="bibr">Wisplinghoff <italic>et al.</italic>, 2003b</xref>). High percentages of fungal
recovery from these institutions (or hematological unit) are to be expected (<xref rid="B22" ref-type="bibr">Martin <italic>et al.</italic>, 2003</xref>). Within
the group of tertiary hospitals and the Pediatric Care Center, the percentages of
positive hemoculture were 6.0% and 13.4%, respectively. Similar rates have been
documented by different authors (<xref rid="B47" ref-type="bibr">Velasco and Bigni,
2008</xref>; <xref rid="B48" ref-type="bibr">Velasco <italic>et al.</italic>,
2000</xref>; <xref rid="B51" ref-type="bibr">Wisplinghoff <italic>et
al.</italic>, 2003a</xref>). Based on these isolations, nowadays the genus
<italic>Candida</italic> is considered the third more frequent pathogen in
infections of stream blood, after <italic>Staphylococcus epidermidis</italic> and
<italic>S. aureus</italic> (<xref rid="B52" ref-type="bibr">Wisplinghoff
<italic>et al.</italic>, 2003b</xref>, <xref rid="B50" ref-type="bibr">2004</xref>).</p><p>The results here documented highlight the high incidence of <italic>C.
albicans</italic> in hospitalized patients. In the present work, <italic>C.
albicans</italic> represented 41.8% of all isolates from the hemoculture. This
percentage agrees with the data recently pointed out regarding this species (48.7%)
by the International Program of Epidemiologic Surveillance (SENTRY), which
investigated the distribution of <italic>Candida</italic> species isolated from
candidemias and their susceptibility profile to antifungics in North America, Latin
America and Europe (<xref rid="B25" ref-type="bibr">Messer <italic>et al.</italic>,
2006</xref>). In Brazil, <italic>C. albicans</italic> has been equally the most
isolated yeast in candidemias in many regions of the country (<xref rid="B03" ref-type="bibr">Aquino <italic>et al.</italic>, 2005</xref>; <xref rid="B05" ref-type="bibr">Barberino <italic>et al.</italic>, 2006</xref>; <xref rid="B31" ref-type="bibr">Passos <italic>et al.</italic>, 2007</xref>). The explanation
for the fact that <italic>C. albicans</italic> presents the highest percentage of
recovery may be related to its large adaptability and pathogenic versatility (<xref rid="B19" ref-type="bibr">Kumamoto and Vinces, 2005</xref>).</p><p>In spite of <italic>C. albicans</italic> being the most frequent agent in this
investigation (41.8%), as a whole, the non-<italic>C. albicans Candida</italic>
species represented the majority of the isolates (58,2%) with preponderancy of
<italic>C. parapsilosis sensu lato</italic> (37.3%) and <italic>C.
tropicalis</italic> (10.4%). Currently, <italic>C. parapsilosis sensu
lato</italic> and <italic>C. tropicalis</italic> correspond conjunctly to about
70% of the non-<italic>C. albicans Candida</italic> isolates from Brazilian
candidemias (<xref rid="B13" ref-type="bibr">Colombo <italic>et al.</italic>,
2006</xref>). The progressive increase in the rates of recovery of
non-<italic>C. albicans Candida</italic> species has been widely related (<xref rid="B07" ref-type="bibr">Bassetti <italic>et al.</italic>, 2011</xref>; <xref rid="B37" ref-type="bibr">Pfaller <italic>et al.</italic>, 2010</xref>). In
Brazil, this tendency was equally confirmed (<xref rid="B27" ref-type="bibr">Nucci
<italic>et al.</italic>, 2010</xref>; <xref rid="B43" ref-type="bibr">Sampaio-Camargo <italic>et al.</italic>, 2010</xref>) and isolation rates up to
75% have been reported to non-<italic>C. albicans Candida</italic> species (<xref rid="B30" ref-type="bibr">Pasqualotto <italic>et al.</italic>, 2005</xref>). The
emergence of non-<italic>C. albicans Candida</italic> isolates may be due to the
selection of more resistant strains because of ostensive use of azoles derivatives
(<xref rid="B21" ref-type="bibr">Mario <italic>et al.</italic>,
2012</xref>).</p><p>In this investigation, blood was the main source of <italic>Candida</italic> species
(47.5%). Nevertheless, the respiratory tract (17.7%), urinary tract (16.3%), skin
and mucous (7.1%) also contributed as important sources. In accordance to the
findings of <xref rid="B16" ref-type="bibr">Comert <italic>et al.</italic>
(2006)</xref>, <italic>C. parapsilosis sensu lato</italic>, <italic>C.
tropicalis</italic> and <italic>C guilliermondii</italic> in the present study
were also the main non-<italic>C. albicans Candida</italic> species recovered from
non-sterile specimens. In spite of the hemoculture being the main marker of invasive
infection (<xref rid="B22" ref-type="bibr">Martin <italic>et al.</italic>,
2003</xref>) and the non-sterile specimens being considered of relative
importance to the infection diagnostic (<xref rid="B49" ref-type="bibr">Wang
<italic>et al.</italic>, 2004</xref>), the isolation of
<italic>Candida</italic> spp. from these specimens may present certain
predictive value for candidemias (<xref rid="B44" ref-type="bibr">Sandford
<italic>et al.</italic>, 1980</xref>), because many invasive processes are
associated to the host's microbiota (<xref rid="B01" ref-type="bibr">Agvald-&#x000d6;hman
<italic>et al.</italic>, 2007</xref>).</p><p>The invasive infections represent high cost to human economy. In the United States
the annual cost with these infections is about US$ 17 billions (<xref rid="B22" ref-type="bibr">Martin <italic>et al.</italic>, 2003</xref>). For the candidemia
treatment, a cost of about US$1 billion per year is estimated (<xref rid="B40" ref-type="bibr">Pfaller <italic>et al.</italic>, 2006b</xref>). Among the
different factors that contribute in a critical way to calculate economical and
social costs of candidemias, it is the microbial resistance to the antifungics of
clinical use (<xref rid="B40" ref-type="bibr">Pfaller <italic>et al.</italic>,
2006b</xref>, <xref rid="B38" ref-type="bibr">2007</xref>). As a result, the
demand for susceptibility tests has been growing (<xref rid="B33" ref-type="bibr">Pfaller, 2012</xref>). The agar disk diffusion method may be useful for the
selection of more effective, non-toxic and less expensive therapies (<xref rid="B38" ref-type="bibr">Pfaller <italic>et al.</italic>, 2007</xref>; <xref rid="B45" ref-type="bibr">Shah <italic>et al.</italic>, 2011</xref>). Its effectiveness in
the confirmation of the susceptibility or in the detection of resistance to
fluconazole has been evaluated in various multicentric international studies (<xref rid="B35" ref-type="bibr">Pfaller <italic>et al.</italic>, 2005</xref>, <xref rid="B38" ref-type="bibr">2007</xref>). Good levels of agreement (87.4 to 97%)
between zone diameters by disk-diffusion method and MIC by CLSI reference
microdilution method has been found (<xref rid="B06" ref-type="bibr">Barry
<italic>et al.</italic>, 2002</xref>; <xref rid="B42" ref-type="bibr">Rodero
<italic>et al.</italic>, 2006</xref>), suggesting an <italic>in vivo/in
vitro</italic> correlation equivalent to the reference method (<xref rid="B24" ref-type="bibr">Meis <italic>et al.</italic>, 2000</xref>).</p><p>In the present study it was demonstrated the low percentage (0.7%) of resistance to
fluconazole, corroborating with what has been reported previously by other authors
(<xref rid="B04" ref-type="bibr">Azevedo, 2011</xref>; <xref rid="B39" ref-type="bibr">Pfaller <italic>et al.</italic>, 2003</xref>, <xref rid="B41" ref-type="bibr">2004</xref>). The only resistant isolate was <italic>C.
krusei</italic> that was recovered from the respiratory tract. The resistance of
this yeast was expected, since it is considered intrinsically resistant to
fluconazole (<xref rid="B16" ref-type="bibr">Comert <italic>et al.</italic>,
2006</xref>). In spite of the occurrence of susceptibility-dose dependent (2.1%
from the total of isolates), 98.4% of <italic>C. albicans</italic> isolates, 97.5%
of <italic>C. parapsilosis sensu lato</italic> isolates and 95.0% of <italic>C.
tropicalis</italic> isolates were susceptible to fluconazole. <xref rid="B35" ref-type="bibr">Pfaller <italic>et al.</italic> (2005</xref>, <xref rid="B36" ref-type="bibr">2007</xref>) also reported similar rates from global studies,
which included the Latin America and Brazil. To <italic>C. famata</italic>,
<italic>C. glabrata</italic>, <italic>C. guilliermondii</italic> and <italic>C.
lambica</italic>, the fluconazole was 100% effective. Nevertheless, acquired
resistance within isolates of <italic>C. glabrata</italic> has been reported (<xref rid="B13" ref-type="bibr">Colombo <italic>et al.</italic>, 2006</xref>; <xref rid="B23" ref-type="bibr">Matta <italic>et al.</italic>, 2007</xref>). The high
susceptibility of <italic>Candida</italic> isolates to fluconazole described here is
also very relevant, since this antifungal medicine is the main available azole drug
to treat invasive fungal infections within Brazilian public hospitals (<xref rid="B09" ref-type="bibr">Brasil, 2007</xref>). The simplicity and validity of
the use of the disk-diffusion method were also confirmed.</p><p>The study on resistance to fluconazole and other antifungals comparing CLSI
disk-diffusion method to CLSI microdilution method and to EUCAST method was
conducted and the results will be published soon, as well as the results of the
study comparing the genotypic and phenotypic identification of these isolates.</p></sec></body><back><ref-list><title>References</title><ref id="B01"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agvald-&#x000d6;hman</surname><given-names>C</given-names></name><name><surname>Klingspor</surname><given-names>L</given-names></name><name><surname>Hjelmqvist</surname><given-names>H</given-names></name><etal/></person-group><year>2007</year><article-title>Invasive candidiasis in long-term patients at a multidisciplinary
intensive care unit: Candida colonization index, risk factors, treatment and
outcome</article-title><source>Scand J Infect Dis</source><volume>31</volume><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="B02"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alangaden</surname><given-names>GJ</given-names></name></person-group><year>2011</year><article-title>Nosocomial fungal infections: epidemiology, infection control,
and prevention</article-title><source>Infect Dis Clin North Am</source><volume>25</volume><fpage>201</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">21316001</pub-id></element-citation></ref><ref id="B03"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aquino</surname><given-names>VR</given-names></name><name><surname>Lunardi</surname><given-names>LW</given-names></name><name><surname>Goldani</surname><given-names>LZ</given-names></name><etal/></person-group><year>2005</year><article-title>Prevalence, susceptibility profile for fluconazole and risk
factors for candidemia in a tertiary care hospital in southern
Brazil</article-title><source>Braz J Infect Dis</source><volume>9</volume><fpage>411</fpage><lpage>4118</lpage><pub-id pub-id-type="pmid">16410893</pub-id></element-citation></ref><ref id="B04"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azevedo</surname><given-names>AC</given-names></name><name><surname>Bizerra</surname><given-names>FC</given-names></name><name><surname>da Matta</surname><given-names>DA</given-names></name><etal/></person-group><year>2011</year><article-title>
<italic>In vitro</italic> susceptibility of a large collection of
<italic>Candida</italic> Strains against fluconazole and voriconazole by
using the CLSI disk diffusion assay</article-title><source>Mycopathologia</source><volume>171</volume><fpage>411</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">21181497</pub-id></element-citation></ref><ref id="B05"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barberino</surname><given-names>MG</given-names></name><name><surname>Silva</surname><given-names>N</given-names></name><name><surname>Rebou&#x000e7;as</surname><given-names>C</given-names></name><etal/></person-group><year>2006</year><article-title>Evaluation of blood stream infections by <italic>Candida</italic>
in three tertiary hospitals in Salvador, Brazil: a case-control
study</article-title><source>Braz J Infect Dis</source><volume>10</volume><fpage>36</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">16767314</pub-id></element-citation></ref><ref id="B06"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>AL</given-names></name><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Rennie</surname><given-names>RP</given-names></name><etal/></person-group><year>2002</year><article-title>Precision and accuracy of fluconazole susceptibility tests by
broth microdilution, Etest and disk diffusion methods</article-title><source>Antimicrob Agents Chemother</source><volume>46</volume><fpage>1781</fpage><lpage>1784</lpage><pub-id pub-id-type="pmid">12019090</pub-id></element-citation></ref><ref id="B07"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassetti</surname><given-names>M</given-names></name><name><surname>Taramasso</surname><given-names>L</given-names></name><name><surname>Nicco</surname><given-names>E</given-names></name><etal/></person-group><year>2011</year><article-title>Epidemiology, species distribution, antifungal susceptibility and
outcome of nosocomial candidemia in a tertiary care hospital in
Italy</article-title><source>PLoS One</source><volume>6</volume><fpage>e24198</fpage><pub-id pub-id-type="pmid">21935385</pub-id></element-citation></ref><ref id="B08"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck-Sagu&#x000e9;</surname><given-names>CM</given-names></name><name><surname>Jarvis</surname><given-names>WR</given-names></name></person-group><person-group person-group-type="author"><collab>National Nosocomial Infections Surveillance System</collab></person-group><year>1993</year><article-title>Secular trends in the epidemiology of nosocomial fungal
infections in the United States, 1980&#x02013;1990</article-title><source>J Infect Dis</source><volume>167</volume><fpage>1247</fpage><lpage>1251</lpage><pub-id pub-id-type="pmid">8486965</pub-id></element-citation></ref><ref id="B09"><element-citation publication-type="book"><person-group person-group-type="author"><collab>Brasil, Minist&#x000e9;rio da Sa&#x000fa;de. Secretaria de Ci&#x000ea;ncia, Tecnologia e
Insumos Estrat&#x000e9;gicos. Departamento de Assist&#x000ea;ncia Farmac&#x000ea;utica e Insumos
Estrat&#x000e9;gicos</collab></person-group><year>2007</year><source>Rela&#x000e7;&#x000e3;o Nacional de Medicamentos Essenciais: RENAME/Minist&#x000e9;rio da Sa&#x000fa;de,
Secretaria de Ci&#x000ea;ncia, Tecnologia e Insumos Estrat&#x000e9;gicos, Departamento de
Assist&#x000ea;ncia Farmac&#x000ea;utica e Insumos Estrat&#x000e9;gicos</source><edition>5&#x000aa;. ed</edition><publisher-loc>Bras&#x000ed;lia</publisher-loc><publisher-name>Editora do Minist&#x000e9;rio da Sa&#x000fa;de</publisher-name><size units="pages">286</size><volume>il</volume><comment>(S&#x000e9;rie B. Textos B&#x000e1;sicos de Sa&#x000fa;de)</comment></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name></person-group><year>2011</year><article-title>The emerging epidemiology of mould infections in developing
countries</article-title><source>Curr Opin Infect Dis</source><volume>24</volume><fpage>521</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">21799406</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>TC</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><etal/></person-group><year>2012</year><article-title>Fluconazole exposure rather than clonal spreading is correlated
with the emergence of <italic>Candida glabrata</italic> with
cross-resistance to triazole antifungal agents</article-title><source>Kaohsiung J Med Sci</source><volume>28</volume><fpage>306</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">22632885</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="book"><person-group person-group-type="author"><collab>CLSI - Clinical and Laboratory Standards Institute</collab></person-group><year>2009</year><source>Publication M44-A2: Method for Antifungal Disk Diffusion Susceptibility
Testing of Yeasts; Approved Guideline - Second Edition</source><publisher-loc>Wayne, PA</publisher-loc><publisher-name>CLSI</publisher-name><volume>29</volume><fpage>1</fpage><lpage>25</lpage></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>AL</given-names></name><name><surname>Nucci</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>BJ</given-names></name><etal/></person-group><year>2006</year><article-title>Epidemiology of candidemia in Brazil: a nationwide sentinel
surveillance of candidemia in eleven medical centers</article-title><source>J Clin Microbiol</source><volume>44</volume><fpage>2816</fpage><lpage>2823</lpage><pub-id pub-id-type="pmid">16891497</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>AL</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>T</given-names></name></person-group><year>2003</year><article-title>Epidemiologia das infec&#x000e7;&#x000f5;es hematog&#x000ea;nicas por
<italic>Candida</italic> spp</article-title><source>Rev Soc Br Med Trop</source><volume>36</volume><fpage>599</fpage><lpage>607</lpage></element-citation></ref><ref id="B15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>AL</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>T</given-names></name><name><surname>Silva</surname><given-names>LR</given-names></name><etal/></person-group><year>2007</year><article-title>Prospective observational study of candidemia in S&#x000e3;o Paulo,
Brazil: incidence rate, epidemiology, and predictors of
mortality</article-title><source>Infect Control Hosp Epidemiol</source><volume>28</volume><fpage>570</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">17464917</pub-id></element-citation></ref><ref id="B16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comert</surname><given-names>F</given-names></name><name><surname>Kulah</surname><given-names>C</given-names></name><name><surname>Aktas</surname><given-names>E</given-names></name><etal/></person-group><year>2006</year><article-title>Identification of <italic>Candida</italic> species isolated from
patient in intensive care unit and <italic>in vitro</italic> susceptibility
to fluconazole for a 3-year period</article-title><source>Mycoses</source><volume>50</volume><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">17302749</pub-id></element-citation></ref><ref id="B17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalmau</surname><given-names>LM</given-names></name></person-group><year>1929</year><article-title>Observations on mycological technique with particular references
to pathogenic fungi</article-title><source>Porto Rico J Pub Heath Trop Med</source><volume>05</volume><fpage>302</fpage><lpage>311</lpage></element-citation></ref><ref id="B18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hospenthal</surname><given-names>DR</given-names></name><name><surname>Murray</surname><given-names>CK</given-names></name><name><surname>Rinaldi</surname><given-names>MG</given-names></name></person-group><year>2004</year><article-title>The role of antifungal susceptibility testing in the therapy of
candidiasis</article-title><source>Diagn Microbiol Infect Dis</source><volume>48</volume><fpage>153</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">15023422</pub-id></element-citation></ref><ref id="B19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumamoto</surname><given-names>CA</given-names></name><name><surname>Vinces</surname><given-names>MD</given-names></name></person-group><year>2005</year><article-title>Contributions of hyphae and hypha-co-regulated genes to
<italic>Candida albicans</italic> virulence</article-title><source>Cell Microbiol</source><volume>7</volume><fpage>1546</fpage><lpage>1554</lpage><pub-id pub-id-type="pmid">16207242</pub-id></element-citation></ref><ref id="B20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lass-Fl&#x000f6;rl</surname><given-names>C</given-names></name><name><surname>Perkhofer</surname><given-names>S</given-names></name><name><surname>Mayr</surname><given-names>A</given-names></name></person-group><year>2010</year><article-title>In vitro susceptibility testing in fungi: a global perspective on
a variety of methods</article-title><source>Mycoses</source><volume>53</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">20078786</pub-id></element-citation></ref><ref id="B21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mario</surname><given-names>DA</given-names></name><name><surname>Denardi</surname><given-names>LB</given-names></name><name><surname>Bandeira</surname><given-names>LA</given-names></name><etal/></person-group><year>2012</year><article-title>The activity of echinocandins, amphotericin B and voriconazole
against fluconazole-susceptible and fluconazole-resistant Brazilian
<italic>Candida glabrata</italic> isolates</article-title><source>Mem Inst Oswaldo Cruz</source><volume>107</volume><fpage>433</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">22510843</pub-id></element-citation></ref><ref id="B22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>GS</given-names></name><name><surname>Mannino</surname><given-names>DM</given-names></name><name><surname>Eaton</surname><given-names>S</given-names></name><etal/></person-group><year>2003</year><article-title>The Epidemiology of sepsis in the United States from 1979 through
2000</article-title><source>N Engl J Med</source><volume>348</volume><fpage>1546</fpage><lpage>1554</lpage><pub-id pub-id-type="pmid">12700374</pub-id></element-citation></ref><ref id="B23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matta</surname><given-names>DA</given-names></name><name><surname>Almeida</surname><given-names>LP</given-names></name><name><surname>Machado</surname><given-names>AM</given-names></name><etal/></person-group><year>2007</year><article-title>Antifungal susceptibility of 1000 <italic>Candida</italic>
bloodstream isolates to 5 antifungal drugs: Results of a multicenter study
conducted in S&#x000e3;o Paulo, Brazil, 1995&#x02013;2003</article-title><source>Diagn Microbiol Infect Dis</source><volume>57</volume><fpage>399</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">17240110</pub-id></element-citation></ref><ref id="B24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meis</surname><given-names>J</given-names></name><name><surname>Petrou</surname><given-names>M</given-names></name><name><surname>Bille</surname><given-names>J</given-names></name><etal/></person-group><year>2000</year><article-title>A global evaluation of the susceptibility of Candida species to
fluconazole by disk diffusion. Global Antifungal Surveillance
Group</article-title><source>Diagn Microbiol Infect Dis</source><volume>36</volume><fpage>215</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">10764963</pub-id></element-citation></ref><ref id="B25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messer</surname><given-names>SA</given-names></name><name><surname>Jones</surname><given-names>RN</given-names></name><name><surname>Fritsche</surname><given-names>TR</given-names></name></person-group><year>2006</year><article-title>International surveillance of <italic>Candida</italic> spp. and
<italic>Aspergillus</italic> spp.: report from the SENTRY Antimicrobial
Surveillance Program (2003)</article-title><source>J Clin Microbiol</source><volume>44</volume><fpage>1782</fpage><lpage>1787</lpage><pub-id pub-id-type="pmid">16672407</pub-id></element-citation></ref><ref id="B26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montravers</surname><given-names>P</given-names></name><name><surname>Jabbour</surname><given-names>K</given-names></name></person-group><year>2006</year><article-title>Clinical consequences of resistant <italic>Candida</italic>
infections in intensive care</article-title><source>Int J Antimicrob Agents</source><volume>27</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16343859</pub-id></element-citation></ref><ref id="B27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nucci</surname><given-names>M</given-names></name><name><surname>Queiroz-Telles</surname><given-names>F</given-names></name><name><surname>Tob&#x000f3;n</surname><given-names>AM</given-names></name><etal/></person-group><year>2010</year><article-title>Epidemiology of opportunistic fungal infections in Latin
America</article-title><source>Clin Infect Dis</source><volume>51</volume><fpage>561</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">20658942</pub-id></element-citation></ref><ref id="B28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nucci</surname><given-names>M</given-names></name><name><surname>Marr</surname><given-names>KA</given-names></name></person-group><year>2005</year><article-title>Emerging fungal diseases</article-title><source>Clin Infect Dis</source><volume>41</volume><fpage>521</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">16028162</pub-id></element-citation></ref><ref id="B29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odds</surname><given-names>FC</given-names></name><name><surname>Bernaerts</surname><given-names>R</given-names></name></person-group><year>1994</year><article-title>CHROMagar <italic>Candida</italic>, a new differential isolation
medium for presumptive identification of clinically important
<italic>Candida</italic> species</article-title><source>J Clin Microbiol</source><volume>32</volume><fpage>1923</fpage><lpage>1929</lpage><pub-id pub-id-type="pmid">7989544</pub-id></element-citation></ref><ref id="B30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasqualotto</surname><given-names>AC</given-names></name><name><surname>Nedel</surname><given-names>WL</given-names></name><name><surname>Machado</surname><given-names>TS</given-names></name><etal/></person-group><year>2005</year><article-title>Risk factors and outcome for nosocomial breakthrough
candidaemia</article-title><source>J Infec</source><volume>60</volume><fpage>129</fpage><lpage>134</lpage></element-citation></ref><ref id="B31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Passos</surname><given-names>XS</given-names></name><name><surname>Costa</surname><given-names>CR</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>CR</given-names></name><etal/></person-group><year>2007</year><article-title>Species distribution and antifungal susceptibility patterns of
<italic>Candida</italic> spp. bloodstream isolates from a Brazilian
tertiary care hospital</article-title><source>Mycopathologia</source><volume>163</volume><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">17334813</pub-id></element-citation></ref><ref id="B32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pem&#x000e1;n</surname><given-names>J</given-names></name><name><surname>Salavert</surname><given-names>M</given-names></name></person-group><year>2012</year><article-title>Epidemiolog&#x000ed;a general de la enfermedad f&#x000fa;ngica
invasora</article-title><source>Enferm Infecc Microbiol Clin</source><volume>30</volume><fpage>90</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">22079232</pub-id></element-citation></ref><ref id="B33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>MA</given-names></name></person-group><year>2012</year><article-title>Antifungal drug resistance: mechanisms, epidemiology, and
consequences for treatment</article-title><source>Am J Med</source><volume>125</volume><fpage>S3</fpage><lpage>S13</lpage><pub-id pub-id-type="pmid">22196207</pub-id></element-citation></ref><ref id="B34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Boyken</surname><given-names>L</given-names></name><name><surname>Hollis</surname><given-names>RJ</given-names></name><etal/></person-group><year>2006a</year><article-title>
<italic>In vitro</italic> susceptibilities of
<italic>Candida</italic> spp. to caspofungin: four years of global
surveillance</article-title><source>J Clin Microbiol</source><volume>44</volume><fpage>760</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">16517851</pub-id></element-citation></ref><ref id="B35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Boyken</surname><given-names>L</given-names></name><name><surname>Messer</surname><given-names>SA</given-names></name><etal/></person-group><year>2005</year><article-title>Comparison of results of voriconazole disk diffusion testing for
<italic>Candida</italic> species with results from a central reference
laboratory in the ARTEMIS global antifungal surveillance
program</article-title><source>J Clin Microbiol</source><volume>43</volume><fpage>5208</fpage><lpage>52013</lpage><pub-id pub-id-type="pmid">16207985</pub-id></element-citation></ref><ref id="B36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Diekema</surname><given-names>DJ</given-names></name></person-group><year>2007</year><article-title>Epidemiology of invasive candidiasis: a persistent public health
problem</article-title><source>Clin Microbiol Rev</source><volume>20</volume><fpage>133</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">17223626</pub-id></element-citation></ref><ref id="B37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Diekema</surname><given-names>DJ</given-names></name><name><surname>Gibbs</surname><given-names>DL</given-names></name><etal/></person-group><year>2010</year><article-title>Results from the ARTEMIS disk global antifungal Surveillance
study, 1997 to 2007: a 10.5 year analysis of susceptibilities of
<italic>Candida</italic> species to fluconazole and voriconazole as
determined by CLSI standardized disk diffusion</article-title><source>J Clin Microbiol</source><volume>48</volume><fpage>1366</fpage><lpage>1377</lpage><pub-id pub-id-type="pmid">20164282</pub-id></element-citation></ref><ref id="B38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Diekema</surname><given-names>DJ</given-names></name><name><surname>Gibbs</surname><given-names>DL</given-names></name><etal/></person-group><year>2007</year><article-title>Results from the ARTEMIS disk global antifungal surveillance
study, 1997 to 2005: an 8.5-year analysis of susceptibilities of
<italic>Candida</italic> species and other yeast species to fluconazole
and voriconazole determined by CLSI standardized disk diffusion
testing</article-title><source>J Clin Microbiol</source><volume>45</volume><fpage>1735</fpage><lpage>1745</lpage><pub-id pub-id-type="pmid">17442797</pub-id></element-citation></ref><ref id="B39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Diekema</surname><given-names>DJ</given-names></name><name><surname>Messer</surname><given-names>SA</given-names></name><etal/></person-group><year>2003</year><article-title>Activities of fluconazole and voriconazole against 1.586 recent
clinical isolates of <italic>Candida</italic> species determined by broth
microdilution disk diffusion and e-test methods: report from the ARTEMIS
global antifungal susceptibility program 2001</article-title><source>J Clin Microbiol</source><volume>41</volume><fpage>1440</fpage><lpage>1446</lpage><pub-id pub-id-type="pmid">12682127</pub-id></element-citation></ref><ref id="B40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Diekema</surname><given-names>DJ</given-names></name><name><surname>Sheehan</surname><given-names>DJ</given-names></name></person-group><year>2006b</year><article-title>Interpretive breakpoints for fluconazole and
<italic>Candida</italic> revisited: a blueprint for the future of
antifungal susceptibility testing</article-title><source>Clin Microbiol Rev</source><volume>19</volume><fpage>435</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">16614256</pub-id></element-citation></ref><ref id="B41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Hazen</surname><given-names>KC</given-names></name><name><surname>Messer</surname><given-names>SA</given-names></name><etal/></person-group><year>2004</year><article-title>Comparison of results of fluconazole disk diffusion testing for
<italic>Candida</italic> species with results from a central reference
laboratory in the ARTEMIS global antifungal surveillance
program</article-title><source>J Clin Microbiol</source><volume>42</volume><fpage>3607</fpage><lpage>3612</lpage><pub-id pub-id-type="pmid">15297505</pub-id></element-citation></ref><ref id="B42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodero</surname><given-names>L</given-names></name><name><surname>C&#x000f3;rdoba</surname><given-names>S</given-names></name><name><surname>Vivot</surname><given-names>W</given-names></name><etal/></person-group><year>2006</year><article-title>M&#x000e9;todo de difusi&#x000f3;n con discos para la determinaci&#x000f3;n de
sensibilidad a fluconazol en aislamientos de <italic>Candida</italic>
spp</article-title><source>Rev Argent Microbiol</source><volume>38</volume><fpage>155</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">17152217</pub-id></element-citation></ref><ref id="B43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampaio-Camargo</surname><given-names>TZ</given-names></name><name><surname>Marra</surname><given-names>AR</given-names></name><name><surname>Silva</surname><given-names>CV</given-names></name><etal/></person-group><year>2010</year><article-title>Secular trends of candidemia in a tertiary care
hospital</article-title><source>Am J Infect Control</source><volume>38</volume><fpage>546</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">20736114</pub-id></element-citation></ref><ref id="B44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandford</surname><given-names>GR</given-names></name><name><surname>Merz</surname><given-names>WG</given-names></name><name><surname>Wingard</surname><given-names>JR</given-names></name><etal/></person-group><year>1980</year><article-title>The value of fungal surveillance cultures as predictors of
sistemic fungal infections</article-title><source>J Infect Dis</source><volume>142</volume><fpage>503</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">7192301</pub-id></element-citation></ref><ref id="B45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>DN</given-names></name><name><surname>Yau</surname><given-names>R</given-names></name><name><surname>Weston</surname><given-names>J</given-names></name><etal/></person-group><year>2011</year><article-title>Evaluation of antifungal therapy in patients with candidaemia
based on susceptibility testing results: implications for antimicrobial
stewardship programmes</article-title><source>J Antimicrob Chemother</source><volume>66</volume><fpage>2146</fpage><lpage>2151</lpage><pub-id pub-id-type="pmid">21700622</pub-id></element-citation></ref><ref id="B46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taschdjian</surname><given-names>CL</given-names></name><name><surname>Burchall</surname><given-names>JJ</given-names></name><name><surname>kozinn</surname><given-names>PJ</given-names></name></person-group><year>1960</year><article-title>Rappid identification of <italic>Candida albicans</italic> by
filamentation on serun and serun substitutes</article-title><source>Am J Dis Children</source><volume>99</volume><fpage>212</fpage><lpage>215</lpage></element-citation></ref><ref id="B47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velasco</surname><given-names>E</given-names></name><name><surname>Bigni</surname><given-names>R</given-names></name></person-group><year>2008</year><article-title>A prospective cohort study evaluating the prognostic impact of
clinical characteristics and comorbid conditions of hospitalized adult and
pediatric cancer patients with candidemia</article-title><source>Eur J Clin Microbiol Infect Dis</source><volume>27</volume><fpage>1071</fpage><lpage>1078</lpage><pub-id pub-id-type="pmid">18548295</pub-id></element-citation></ref><ref id="B48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velasco</surname><given-names>E</given-names></name><name><surname>Thuler</surname><given-names>LC</given-names></name><name><surname>Martins</surname><given-names>CA</given-names></name><etal/></person-group><year>2000</year><article-title>Epidemiology of bloodstream infections at a cancer
center</article-title><source>S&#x000e3;o Paulo Med J</source><volume>118</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">11018846</pub-id></element-citation></ref><ref id="B49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JL</given-names></name><name><surname>Chang</surname><given-names>SC</given-names></name><name><surname>Hsueh</surname><given-names>PR</given-names></name><etal/></person-group><year>2004</year><article-title>Species distribution and fluconazole susceptibility of
<italic>Candida</italic> clinical isolates in a medical center in
2002</article-title><source>J Microbiol Immunol Infect</source><volume>37</volume><fpage>236</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">15340652</pub-id></element-citation></ref><ref id="B50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisplinghoff</surname><given-names>H</given-names></name><name><surname>Bischoff</surname><given-names>T</given-names></name><name><surname>Tallent</surname><given-names>SM</given-names></name><etal/></person-group><year>2004</year><article-title>Nosocomial bloodstream infections in US hospitals: analysis of
24,179 cases from a prospective nationwide surveillance
study</article-title><source>Clin Infect Dis</source><volume>39</volume><fpage>309</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">15306996</pub-id></element-citation></ref><ref id="B51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisplinghoff</surname><given-names>H</given-names></name><name><surname>Seifert</surname><given-names>H</given-names></name><name><surname>Tallent</surname><given-names>SM</given-names></name><etal/></person-group><year>2003a</year><article-title>Nosocomial bloodstream infections in pediatric patients in United
States hospitals: epidemiology, clinical features and
susceptibilities</article-title><source>Pediatr Infect Dis J</source><volume>22</volume><fpage>686</fpage><lpage>691</lpage><pub-id pub-id-type="pmid">12913767</pub-id></element-citation></ref><ref id="B52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisplinghoff</surname><given-names>H</given-names></name><name><surname>Seifert</surname><given-names>H</given-names></name><name><surname>Wenzel</surname><given-names>RP</given-names></name><etal/></person-group><year>2003b</year><article-title>Current trends in the epidemiology of nosocomial bloodstream
infections in patients with hematological malignancies and solid neoplasms
in hospitals in the United States</article-title><source>Clin Infect Dis</source><volume>36</volume><fpage>1103</fpage><lpage>1110</lpage><pub-id pub-id-type="pmid">12715303</pub-id></element-citation></ref></ref-list></back></article>